OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis
Miles Piper, Maureen Hoen, Laurel B. Darragh, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 950-969.e6
Open Access | Times Cited: 48
Miles Piper, Maureen Hoen, Laurel B. Darragh, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 950-969.e6
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18
IL-2-driven CD8+ T cell phenotypes: implications for immunotherapy
Veronika Niederlová, Oksana Tsyklauri, Marek Kovář, et al.
Trends in Immunology (2023) Vol. 44, Iss. 11, pp. 890-901
Open Access | Times Cited: 27
Veronika Niederlová, Oksana Tsyklauri, Marek Kovář, et al.
Trends in Immunology (2023) Vol. 44, Iss. 11, pp. 890-901
Open Access | Times Cited: 27
Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs
Laurel B. Darragh, Alexander Nguyen, Tiffany Pham, et al.
Med (2024) Vol. 5, Iss. 3, pp. 254-270.e8
Closed Access | Times Cited: 10
Laurel B. Darragh, Alexander Nguyen, Tiffany Pham, et al.
Med (2024) Vol. 5, Iss. 3, pp. 254-270.e8
Closed Access | Times Cited: 10
PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment
Céline Godfroid, Jackeline F. Romero, Sara Labiano, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009832-e009832
Open Access | Times Cited: 1
Céline Godfroid, Jackeline F. Romero, Sara Labiano, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009832-e009832
Open Access | Times Cited: 1
Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Olamide Tosin Olaoba, Ming Yang, Temitope Isaac Adelusi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1470-1470
Open Access | Times Cited: 5
Olamide Tosin Olaoba, Ming Yang, Temitope Isaac Adelusi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1470-1470
Open Access | Times Cited: 5
IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p
Ehsan Gharib, Leili Rejali, Moein Piroozkhah, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Ehsan Gharib, Leili Rejali, Moein Piroozkhah, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice
Carmine Carbone, R. De Luca, Emanuele Puca, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Carmine Carbone, R. De Luca, Emanuele Puca, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment
Jacob Gadwa, Justin Yu, Miles Piper, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010405-e010405
Open Access
Jacob Gadwa, Justin Yu, Miles Piper, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010405-e010405
Open Access
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy
Kengo Tanigawa, William L. Redmond
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Kengo Tanigawa, William L. Redmond
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma
Enoch Chang, Alexander D. Sherry, Jakob Liermann, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Enoch Chang, Alexander D. Sherry, Jakob Liermann, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Based on the immune system: the role of the IL-2 family in pancreatic disease
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Development of Novel Short Peptide Inhibitor Targeted to Immune Checkpoint PD-1 LBD
Xingyan Zhu, Yuping Wei, Man Zhang, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 3
Closed Access
Xingyan Zhu, Yuping Wei, Man Zhang, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 3
Closed Access
Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer
Enkui Zhang, Yongsu Ma, Zonghao Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Enkui Zhang, Yongsu Ma, Zonghao Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access
Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies
Julien Montorfani, Eric Hatterer, Laurence Chatel, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010650-e010650
Open Access
Julien Montorfani, Eric Hatterer, Laurence Chatel, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010650-e010650
Open Access
Orchestrating T and NK cells for tumor immunotherapy via NKG2A-targeted delivery of a de novo designed IL-2Rβγ agonist
Jie Chen, Enhui Ren, Ze Tao, et al.
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access
Jie Chen, Enhui Ren, Ze Tao, et al.
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access
Dual Facets of Ionizing Radiation in Cancer Therapy: Immunomodulation and Immunosuppression
Ao Sun, Xu Huai, Wenjing Tao, et al.
(2025), pp. 233-262
Closed Access
Ao Sun, Xu Huai, Wenjing Tao, et al.
(2025), pp. 233-262
Closed Access
The Combination of Immunotherapy and Radiotherapy in Pancreatic Ductal Adenocarcinoma
Bi Peng, Ziqi Chen, Liu Y
(2025), pp. 159-168
Closed Access
Bi Peng, Ziqi Chen, Liu Y
(2025), pp. 159-168
Closed Access
Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data
Logan V. Vick, Robert J. Canter, Arta M. Monjazeb, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 88-102
Open Access | Times Cited: 10
Logan V. Vick, Robert J. Canter, Arta M. Monjazeb, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 88-102
Open Access | Times Cited: 10
A new target of radiotherapy combined with immunotherapy: regulatory T cells
Dongmei Song, Yun Ding
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Dongmei Song, Yun Ding
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Tissue-resident NK cells support survival in pancreatic cancer through promotion of cDC1-CD8T activity
Simei Go, Constantinos Demetriou, Sophie Hughes, et al.
(2024)
Open Access | Times Cited: 3
Simei Go, Constantinos Demetriou, Sophie Hughes, et al.
(2024)
Open Access | Times Cited: 3
Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity
Lina Sun, Anjun Jiao, Haiyan Liu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Lina Sun, Anjun Jiao, Haiyan Liu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
